Inozyme Pharma Inc (INZY)
0.9645 -0.0197 (-2.00%) 04/28/25 [NASDAQ]
0.8800 x 100 1.1900 x 300
Realtime by (Cboe BZX)
0.8800 x 100 1.1900 x 300
Realtime - - (-) -
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,024 | -71,169 | -67,061 | -56,624 | -56,424 |
| Depreciation Amortization | -4,297 | -4,605 | -927 | 844 | 494 |
| Accounts payable and accrued liabilities | 1,364 | -1,378 | 150 | -675 | 2,098 |
| Other Working Capital | 4,714 | -3,082 | 2,012 | 85 | -111 |
| Other Operating Activity | 8,336 | 9,559 | 8,065 | 8,217 | 17,969 |
| Operating Cash Flow | $-91,907 | $-70,675 | $-57,761 | $-48,153 | $-35,974 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 67,060 | -53,348 | -4,993 | 43,193 | -116,611 |
| PPE Investments | -62 | -298 | -410 | -397 | -568 |
| Investing Cash Flow | $66,998 | $-53,646 | $-5,403 | $42,796 | $-117,179 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 40,000 | 4,050 | 0 | N/A |
| Common Stock Issued | 11,398 | 85,969 | 68,738 | 609 | 116,174 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 33,638 |
| Financing Cash Flow | $11,398 | $125,969 | $72,788 | $609 | $149,812 |
| Exchange Rate Effect | 4 | -18 | -25 | 24 | 0 |
| Beginning Cash Position | 34,899 | 33,269 | 23,670 | 28,394 | 31,735 |
| End Cash Position | 21,392 | 34,899 | 33,269 | 23,670 | 28,394 |
| Net Cash Flow | $-13,507 | $1,630 | $9,599 | $-4,724 | $-3,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,907 | -70,675 | -57,761 | -48,153 | -35,974 |
| Capital Expenditure | -62 | -298 | -410 | -397 | -568 |
| Free Cash Flow | -91,969 | -70,973 | -58,171 | -48,550 | -36,542 |